Synovex Choice® receives additional label indication for dry lot cattle
Zoetis has received an expanded label approval from the Food and Drug Administration's Center for Veterinary Medicine for Synovex Choice® to increase rate of weight gain in growing beef steers or heifers in the dry lot production phase.
April 17, 2024
PARSIPPANY, N.J., — Zoetis announced today it has received an expanded label approval from the Food and Drug Administration's Center for Veterinary Medicine (CVM) for Synovex Choice® to increase rate of weight gain in growing beef steers or heifers in the dry lot production phase. Also approved is a new implant from Zoetis, Synovex® Primer™ that will be available for the dry lot market later in 2024.
“This approval provides beef producers with dry lot operations another tool to help them meet their production and profitability goals,” said John Hallberg, DVM, PhD, U.S. director of regulatory affairs, Zoetis. “As the first trenbolone acetate (TBA) implants approved for dry lot production, steers and heifers have the opportunity to gain additional weight with the appropriate nutritional inputs.”
Effective immediately, existing packages of Synovex Choice can be used in the dry lot production phase. Animal health product suppliers and cattle producers will begin seeing packaging for Synovex Choice with the updated indications by the end of 2024.